Preeclampsia Subtypes and Surrogate Markers of CVD Risk
NCT ID: NCT02337049
Last Updated: 2015-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2014-09-30
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Eligible participants delivered at the Department of Obstetrics at Randers Regional Hospital 1998-2008.
Early-onset preeclampsia is defined as preeclampsia that develops before 34 weeks of gestation, whereas late-onset preeclampsia develops at or after 34 weeks of gestation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preeclampsia and Circulating Biomarkers
NCT02136667
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708
Prospective Study in Pregnant Women With Hypercoagulopathy
NCT00215969
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)
NCT07263490
Left Ventricular and Endothelial Function in Preeclampsia
NCT00201500
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Previously early onset preeclampsia
Women with a history of early onset preeclampsia 10 years ago
No interventions assigned to this group
Previously late onset preeclampsia
Women with a history of late onset preeclampsia 10 years ago
No interventions assigned to this group
Previously normotensive pregnancy
Women with a history of normotensive pregnancies 10 years ago
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Randers Regional Hospital
OTHER
Karen Elise Jensen Foundation
OTHER
Central Denmark Region
OTHER
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ulla B Knudsen, Professor
Role: STUDY_CHAIR
Department of Obstetrics and Gynaecology, Aarhus University Hos
Martin Christensen, MD
Role: PRINCIPAL_INVESTIGATOR
Clinical Research Unit, Randers Regional Hospital
Camilla S Kronborg, MD, PhD
Role: STUDY_DIRECTOR
Department of Oncology, Aarhus University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Randers Regional Hospital
Randers, Randers NØ, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
26702017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.